Cheryl Deeley

3.8k total citations
10 papers, 582 citations indexed

About

Cheryl Deeley is a scholar working on Neurology, Clinical Psychology and Cognitive Neuroscience. According to data from OpenAlex, Cheryl Deeley has authored 10 papers receiving a total of 582 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Neurology, 5 papers in Clinical Psychology and 4 papers in Cognitive Neuroscience. Recurrent topics in Cheryl Deeley's work include Obsessive-Compulsive Spectrum Disorders (5 papers), Parkinson's Disease Mechanisms and Treatments (5 papers) and Autism Spectrum Disorder Research (3 papers). Cheryl Deeley is often cited by papers focused on Obsessive-Compulsive Spectrum Disorders (5 papers), Parkinson's Disease Mechanisms and Treatments (5 papers) and Autism Spectrum Disorder Research (3 papers). Cheryl Deeley collaborates with scholars based in United States. Cheryl Deeley's co-authors include Roger Kurlan, Peter G. Como, Bridget Miller, E. M. Andresen, Michael McDermott, Donna Palumbo, M. P. McDermott, Christine Brower, Sandra Plumb and Radu Constantinescu and has published in prestigious journals such as Neurology, Annals of Neurology and Journal of General Internal Medicine.

In The Last Decade

Cheryl Deeley

10 papers receiving 555 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Cheryl Deeley United States 7 458 295 177 92 41 10 582
Miran Salgado United States 4 94 0.2× 267 0.9× 100 0.6× 124 1.3× 27 0.7× 5 375
Carolyn Kwak United States 7 352 0.8× 345 1.2× 81 0.5× 377 4.1× 91 2.2× 8 728
Singh Jaswinder United States 8 45 0.1× 318 1.1× 81 0.5× 127 1.4× 47 1.1× 10 419
Melanie Jonas Germany 11 238 0.5× 303 1.0× 53 0.3× 55 0.6× 41 1.0× 16 437
David Emmans Germany 7 40 0.1× 250 0.8× 71 0.4× 127 1.4× 46 1.1× 9 417
Tara D. Lipps United States 7 188 0.4× 196 0.7× 170 1.0× 63 0.7× 11 0.3× 10 412
Simon Laganiere United States 5 38 0.1× 256 0.9× 116 0.7× 171 1.9× 24 0.6× 5 452
Heidi Roth United States 13 55 0.1× 257 0.9× 86 0.5× 35 0.4× 75 1.8× 28 421
Chiara Giacosa Canada 9 79 0.2× 224 0.8× 48 0.3× 28 0.3× 80 2.0× 10 387
Therese English Australia 7 71 0.2× 360 1.2× 92 0.5× 44 0.5× 34 0.8× 7 520

Countries citing papers authored by Cheryl Deeley

Since Specialization
Citations

This map shows the geographic impact of Cheryl Deeley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cheryl Deeley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cheryl Deeley more than expected).

Fields of papers citing papers by Cheryl Deeley

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cheryl Deeley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cheryl Deeley. The network helps show where Cheryl Deeley may publish in the future.

Co-authorship network of co-authors of Cheryl Deeley

This figure shows the co-authorship network connecting the top 25 collaborators of Cheryl Deeley. A scholar is included among the top collaborators of Cheryl Deeley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cheryl Deeley. Cheryl Deeley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Simuni, T., et al.. (2009). P2.161 STEADY-PD: safety, tolerability, and efflcacy assessment of isradipine (Dynacirc CR) in early Parkinson disease. Parkinsonism & Related Disorders. 15. S133–S133. 1 indexed citations
2.
Constantinescu, Radu, et al.. (2006). Assistive devices for gait in Parkinson's disease. Parkinsonism & Related Disorders. 13(3). 133–138. 45 indexed citations
3.
Kurlan, Roger, Irene Hegeman Richard, & Cheryl Deeley. (2006). Medication Tolerance and Augmentation in Restless Legs Syndrome: The Need for Drug Class Rotation. Journal of General Internal Medicine. 21(12). C1–C4. 20 indexed citations
4.
Kurlan, Roger, Irene Hegeman Richard, & Cheryl Deeley. (2006). Medication tolerance and augmentation in restless legs syndrome: The need for drug class rotation. Journal of General Internal Medicine. 21(12). 1338–1338. 1 indexed citations
5.
Kurlan, Roger, Peter G. Como, Bridget Miller, et al.. (2002). The behavioral spectrum of tic disorders. Neurology. 59(3). 414–420. 184 indexed citations
6.
Kurlan, Roger, M. P. McDermott, Cheryl Deeley, et al.. (2001). Prevalence of tics in schoolchildren and association with placement in special education. Neurology. 57(8). 1383–1388. 144 indexed citations
7.
Abwender, David A., Peter G. Como, Roger Kurlan, et al.. (1996). School Problems in Tourette's Syndrome. Archives of Neurology. 53(6). 509–511. 65 indexed citations
8.
Kurlan, Roger, Caroline M. Tanner, Christopher G. Goetz, et al.. (1994). Levodopa Drug Holiday Versus Drug Dosage Reduction in Parkinsonʼs Disease. Clinical Neuropharmacology. 17(2). 117–127. 5 indexed citations
9.
Kurlan, Roger, Peter G. Como, Cheryl Deeley, & Michael McDermott. (1993). A Pilot Controlled Study of Fluoxetine for Obsessive-Compulsive Symptoms in Children with Touretteʼs Syndrome. Clinical Neuropharmacology. 16(2). 167–172. 64 indexed citations
10.
Kurlan, Roger, et al.. (1991). A controlled trial of propoxyphene and naltrexone in patients with tourette's syndrome. Annals of Neurology. 30(1). 19–23. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026